Akero Therapeutics Inc buy Morgan Stanley
Start price
11.10.23
/
50%
€14.00
Target price
11.10.24
€31.05
Performance (%)
92.86%
End price
12.10.24
€27.00
Summary
This prediction ended on 12.10.24 with a price of €27.00. With a performance of 92.86% the BUY prediction by Morgan_Stanley was a big success. Morgan_Stanley has a follow-up prediction for Akero Therapeutics Inc where he still thinks Akero Therapeutics Inc is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | - | - | 70.552% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by Morgan_Stanley for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target lowered by analysts at Morgan Stanley from $70.00 to $33.00. They now have an "overweight" rating on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€49.44
28.01.25
28.01.25
€92.02
28.01.26
28.01.26
-5.00%
08.12.25
08.12.25
Stopped prediction by Morgan_Stanley for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€38.28
10.03.25
10.03.25
-
10.03.26
10.03.26
22.70%
08.12.25
08.12.25